equally applicable to detection of drugs in urine, blood, saliva, and tissues. All of them are done at ambient temperature and can be used equally well for emergency (stat) tests or mass screening. Except for the benzoylecgonine assay, the clinical reliability of these tests has been demonstrated. The use of radioimmunoassays (RIA) for detection of drugs of abuse has been documented (1) (2) (3) (4) (5) (6) (7) (8) . Com- parative studies on drug detection by physical and immunological means, including RIA, have also appeared (9) (10) (11) (12) (13) (14) . In most instances, radioimmunoassays have been used for screening urine specimens, although detection by RIA of barbiturates or morphine and its analogs in blood (1, 3) and of morphine and its analogs or methadone in autopsy tissues has also been reported (15, 16) . Development of these radioimmunoassays was based on the original work of Spector and Parker (17) , who first successfully obtained antibodies to morphine by coupling 3-O-carboxymethylmorphine to bovine serum albumin for use as the antigen. With a derivative of secobarbital for the hapten portion of the antigen, the feasibility of a radioimmunoassay for detection of barbiturates was later demonstrated (18, 19) . These experimental studies were done with 3H-or 14C-labeled antigens.
During our initial development of RIA's for use to detect abused drugs, it became apparent that 1251-labeled antigens would be preferable to tritiated or '4C-labeled antigens for widespread application as a rapid, less-expensive assay. Therefore, our efforts were primarily directed toward development of assays utilizing derivatives of the appropriate antigen that could be readily iodinated.
However, an assay with use of tritiated dihydromorphine is also currently available. To date, radioimmunoassays have been developed in our laboratories for detection of morphine, barbiturates, amphetamine, methadone, methaqualone, and benzoylecgonine, as well as combination assays to test for two or more of these drugs simultaneously.
To facilitate multiple testing for several drugs of abuse, the various individual radioimmunoassays have been designed to be performed in an identical manner. The combined assays are done like the individual assays, except that two or more iodinated antigens and specific antibodies are combined, stored, and used in this premixed form. Here, we review the status of these assays as to their applicability to rapid drug screening, quantitation of drugs in biological specimens, limits of sensitivity, specificity, and stability in terms of usable shelf life of the reagents.
In addition, general problems related to development of all assays such as preparation of antibody pools with consistent specificity and binding characteristics will be discussed. Table  1 lists the reagents  for the individual  and  combined  RIA's utilizing  1251-labeled antigens,  while  Table 2 contains a general outline of the assay procedures. Antiserum prepared against specific haptens by procedures similar to those described by Spector and Parker (17) . Antisera were diluted in serum from unimmunized animals, then further diluted with an equal volume of PBS. Prepared in do-ionized water and used without neutralization.
Methodology
All standards prepared from pools of urine tested and found by RIA not to give appreciable differences in counts per minute from expected background. Standards were prepared as concentrated solutions in appropriate solvents and then diluted in pooled urine to give the desired concentration.
Combined reagents
Antigen-1251-labeled morphine and 1251-labeled antibody, secobarbital derivative combined (dual assay) or containing an additional 1251-labeled amphetamine derivative (triple assay). The combined labeled antigens were diluted in PBS, pH 7.2, to appropriate radioactive concentrations. Goat antiserum to each of the antigens was diluted in normal goat serum to appropriate concentrations and mixed with an equal volume of PBS. The diluted antibody reagent was added to an equal volume of combined antigen reagent and allowed to equilibrate for at least 24 h at 4 #{176}C. 4. Incubate for at least 10 mm at ambient temperature. 5. Add 0.5 ml of saturated ammonium sulfate solution, mix well.
#{149} An assay
6. Incubate for 5-10 mm at ambient temperature. 7. Centrifuge in swinging bucket rotor for 10 mm at 1250-2500 X g. Withdraw 0.5 ml of supernate from each tube and transfer it to appropriate tube for counting in a gamma scintillation counter.
CombIned reagents
Into 10 X 75 or 12 X 75 mm glass tubes: 1. Add 0.1 ml of standards and unknowns to separate tubes. 2. Add 0.4 ml of combined reagents to each tube, mix well. 3. incubate for at least 1 h at ambient temperature. 4. Continue as above from step 5.
#{149} Assay procedure with use of tritlated morphine has been described pre-
Quantitation.
For Figure 2 .
From the data presented in Figure 2 one can see that a 30-fold dilution of Pool 1 gives a standard curve very similar to that seen with a 40-fold dilution of Pool 3. Pool 1 is the reference antiserum pool for both avidity and cross-reactivity. b After a pattern of low reactivity had been set over a period of several months, these compounds were no longer routinely tested. Table  3 ).
of least squares.
The program uses calculated cpm values to determine whether the tested serum sample meets the required specifications. Because the determination of acceptable avidity depends on differences in cpm between individual points, the use of calculated cpm values minimizes the effect of random error. Using the equation for the fitted line and cpm values associated with the cross-reactants, amphetamine equivalents for each cross-reactant are calculated. Only those sera that are acceptable under criteria for both avidity and cross-reaction are pooled for use in the assay. Table 3 shows the compounds tested, with ranges of cross-reactivity encountered, while 
45#{176}C

Abscissa, pg/liter
Representative data for stability of the methaqualone reagents held for three months are shown in Figures 5 (response curve) and 6 (relative percent binding). Satisfactory performance was obtained for at least three months at 4, 25, and 37 #{176}C but not at 45 #{176}C.
For the methadone reagents, performance in terms of response ( Figure 7) was satisfactory for at least three months at 4 #{176}C. However, the relative percent binding curves (Figure 8) show a marked trend toward reduced binding, indicating degradation of antigen or antibody. This degradation was greatly accelerated when the reagents were held at elevated temperatures.
At 25 #{176}C the reagents were stable for two weeks; at 37 and 45 #{176}C, for only one week.
The stability profile for the combined barbiturate! morphine assay has been previously reported (6) . We observed that the relative percent of unbound antigens were essentially unchanged at 4 and 25#{176}C after storage for three months.
During the same time the actual radioactivity (cpm) decreased as expected while the curves remained paired (6 
125J
labeled antigens were essentially unchanged at 4, 25, and 37 #{176}C after storage for three months.
At 45 #{176}C, a decreased response was evident.
In terms of response curve, the reagent was stable at 4 #{176}C during the three month period. The counts per minute at each drug concentration decreased owing to radioactive decay, but the individual curves remained well matched (See Figures 10 and 11) .
Our preliminary data suggest to us that the reagents for the benzoylecgonine assay are stable for about three months at 4 and 25 #{176}C.
Clinical and Experimental Results
Morphine
Because the morphine RIA is available with either 3H-or 1251-labeled antigen, it was important to demonstrate that the reagents prepared with either label would quantitatively detect morphine or its metabolite, morphine glucuronide, with comparable sensitivity. Therefore, a volunteer was given 10 mg of morphine per 70 kg body weight, intravenously, and urine samples were collected over a 72-h period and the amount of drug, in terms of morphine equivalents, determined both by the tritium and the iodine assay (Table 6 ). Evidently both assays detect the morphine or morphine glucuronide in this individual's urine to about the same extent. The specificity of the morphine RIA for morphine and related analogs (i.e., codeine, heroin, and levorotatory morphinans) has been previously described (1, 5, 13) . The sensitivity of this RIA for detection of morphine in the urine of addicts or volunteers for periods of at least 72 h after hroin or morphine administration has also been demonstrated (1, 9, 10; see Tables 6, 12, and 14 herein).
Barbiturates
In the barbiturate assay, secobarbital derivatives were used to prepare both antigen and antibody.
When other barbiturates were used as the unlabeled standards the sensitivity of the assay could be increased ( 
Amphetamine
Amphetamine is not notably metabolized in humans, so the greater portion of an administered dose appears as amphetamine in the urine. Thus, the amphetamine RIA was designed to detect amphetamine itself. A clinical study that we did with human volunteers showed that the assay can detect the use of moderate doses of amphetamine with a high degree of reliability. Four subjects received oral doses of either 15 or 30 mg of d-amphetamine sulfate (three doses of either 5 or 10 mg over a period of about 12 h). The total urine volume excreted during fixed time intervals up to five days after the first dose was collected and assayed. Table 9 shows that there was individual variation in the pattern of amphetamine excretion. Three of the four subjects had high urinary amphetamine concentrations within 1 h of the first dose (i.e., >1000 tg/liter).
High concentrations were detected in the urines of all four subjects for as long as two days after the first dose, and one of the four had a high value for three days after the first dose.
In a similar study, 18 volunteer subjects received single oral doses of drugs other than amphetamine -10000  2000  1100  6500  3200  450  110  26   15  0  0  140  900  500  2300  2700  260  170  46  30  8  1700  3600  5400  8400  7800  3800  440  220  17  30  2  6400  4400  4100  6500  4600  4400  4900  600 The total urine excreted within fixed time intervals up to 120 h following ingestion of the drug was collected and tested by radioimmunoassay.
In all four subjects, the first specimen (0-1 h) gave a value exceeding 500 gig/liter (the most concentrated standard used) and remained so for the duration of the study. After appropriate dilutions of these specimens in normal human urine, drug concentrations in the specimens were found to range from 1550 hg/liter (at 96-120 h) to about 55 000 g/lithr (at 1-4 h) in terms of methaqualone equivalents. In another experiment, human volunteers were administered standard doses of the drugs listed in Table  11 and the total urine excreted within fixed time intervals up to 120 h was collected and assayed. The highest value for methaqualone equivalents encountered was 32 ,g/liter, which is within the normal range. Of the 267 specimens assayed, 260 (97%) tested at 20 tg/liter or less. Berman et al. (4) reported no cross-reactions with normal urines that had been supplemented with high concentrations of drugs of abuse other than methaqualone.
Benzoylecgonine O-Benzoylecgonine is the major urinary metabolite of cocaine.
A radioimmunoassay with a 1251-labeled antigen to detect this metabolite has been developed and tested, but is still in an experimental stage. The following summary is based on the data available. A random sample of 100 "normal" urines was tested, to determine the range of apparent benzoylecgonine concentrations to be expected in a normal population. The results ranged from 0 to 11 gfliter.
Thus, a cutoff value of 100 ag/liter for the qualitative assay appears to be well above the normal range.
The test appears to be quite specific for benzoylecgonine.
Some potentially cross-reacting compounds were dissolved in normal human urine and tested. Cocaine at 10 000 ag/liter was equivalent to 590 g of benzoylecgonine per liter (5.9% as reactive as benzoylecgonine).
However, the response to cocaine in terms of benzoylecgonine equivalents was not proportional to the concentration of cocaine. For example, 1000 zg of cocaine per liter was equivalent to 330 g of benzoylecgonine per liter (33% as reactive as benzoylecgonine). Ecgonine, 10 000 tg/liter, produced a response equivalent to only 53 gfliter of benzoylecgonine. Atropine and (-)scopolamine hydrobromide, both of which are also tropine derivatives, gave negligible responses. Procaine hydrochloride, 10 000 pig/liter, produced a response equivalent to only 5 gig/liter of benzoylecgonme.
Combined Radioimmunoassays
Because of the independent, flexible nature of RIA's, two single assays can be combined to give a dual assay by carefully manipulating the concentrations of antigens and antibodies.
A positive result in such a test indicates the presence of either or both drugs, which can then be identified by using the individual RIA's. The feasibility of simultaneously testing for two classes of drugs of abuse while maintaining stability, specificity, and sensitivity equivalent to the individual assays has been demonstrated with morphine and barbiturate (5, 6) .
The possibility of developing a radioimmunoassay for three drugs-namely, morphine, barbiturates, and amphetamine-was investigated.
The triple-assay reagent was prepared as a mixture of labeled antigens and corresponding antibodies. Figure 10 shows that the individual response curves for morphine, barbiturate, and amphetamine can be closely superimposed. Our data make it apparent that a combined RIA for detection of the presence of one or more of three drugs can be developed.
Clinical evaluation of the assay for three drugs has not been done.
Use of Discs Impregnated with Urine
In any large-scale drug testing program involving urine specimens, the problems of transportation, storage, and identification can be significant. We therefore investigated the feasibility of using paper discs impregnated with test urines, to eliminate the need for liquid urine samples for testing. Standard 6.35-mm Schleicher and Schuell (S&S) discs No. 740-E were soaked for 30 mm in urine of individuals receiving known drugs; the discs were then dried at 37 #{176}C for 2 h on plastic sheets and stored at room temperature until used about one week later. These discs, when saturated, absorb 50 l of fluid and can be assayed directly by folding them in half and dropping them into 12 X 75 mm tubes to which the RIA reagents are then added. After incubation at ambient temperature for 1 h, the procedure outlined in Table 2  (precipitation  with saturated   ammonium sulfate solution, centrifugation, and removal of 0.5 ml of supernate for counting) is done without removing the disc from the tube.
For the morphine assay, two calibration curves were prepared.
One with use of urines containing 0, 20,40,80, and 160 g of morphine per liter. In the other we used discs that were soaked in the same urine standards, dried, and used without further treatment. Similar calibration curves were prepared for the barbiturate assays, with 0, 50, 100, 200, 400, 800, and 1600 gig/liter secobarbital standards.
The calibration curves, after for the difference in volume between disc (0.05 ml) and liquid standards (0.1 ml), were superimposable on each other for both morphine and secobarbital. Table 12 shows results of assays with urines from three individuals receiving morphine and Table  13  shows those for urmnes from three individuals  receiving  secobarbital, butabarbital, and glutethimide, respectively. In both tables, the raw cpm counts for discs and liquid specimens as well as pg/liter equivalents after interpolation from the disc and liquid reference curves are presented.
At the 72-84 h test period for subject 1 ( Calibration curves were prepared with standards prepared in urine, serum, and saliva that were negative for morphine. Table 14 summarizes our results. The levels of morphine and metabolites were higher in urine than in the serum and could be detected for a considerably longer period of time (i.e., 72 vs. 6-8 h), confirming our earlier observations (1) . It is also apparent that the concentrations of morphine in saliva are in most instances lower than those in serum and can be detected reliably only for 2-6 h.
We also examined how well RIA can detect barbiturates in plasma and saliva as compared to urine. Tn- for 72 h in all urine, serum and saliva specimens (Table 15) . Although values were generally higher in urine than in serum or saliva, both serum and saliva values exceeded 100 jLglliter even after 72 h. These results suggest that for detection of barbiturates, serum and saliva would both be acceptable test specimens. The ability to detect methaqualone and benzoylecgonine by RIA in various biological fluids other than urine is now being investigated.
Discussion
It is apparent that these radioimmunoassays are sensitive and specific for detecting abused drugs, not only in urine, but in various other biological fluids and tissues.
The advantage of using this type of assay is two-fold: 1. A negative result is strong evidence that clinically significant amounts of the drug in question are not present and therefore more laborious analytical procedures are not necessary.
2. Because of the sensitivity, it is usually possible to detect the agent sought for a longer time after drug administration than is possible with other methods. The assays are so formulated that they are simple to do and can be quickly completed. 
